Legal & General Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02B | Sell |
16,877,626
-488,406
| -3% | -$28.5M | 0.24% | 76 |
|
|
2025
Q4 | $937M | Buy |
17,366,032
+290,289
| +2% | +$14M | 0.21% | 92 |
|
|
2025
Q3 | $770M | Buy |
17,075,743
+1,317,199
| +8% | +$61.5M | 0.17% | 106 |
|
|
2025
Q2 | $729M | Sell |
15,758,544
-707,829
| -4% | -$34.7M | 0.18% | 104 |
|
|
2025
Q1 | $1B | Buy |
16,466,373
+340,567
| +2% | +$19.9M | 0.27% | 64 |
|
|
2024
Q4 | $912M | Sell |
16,125,806
-546,072
| -3% | -$30.5M | 0.24% | 71 |
|
|
2024
Q3 | $863M | Buy |
16,671,878
+138,273
| +0.8% | +$6.49M | 0.23% | 78 |
|
|
2024
Q2 | $687M | Buy |
16,533,605
+88,834
| +0.5% | +$3.97M | 0.19% | 93 |
|
|
2024
Q1 | $892M | Sell |
16,444,771
-248,254
| -1% | -$12.6M | 0.26% | 69 |
|
|
2023
Q4 | $857M | Sell |
16,693,025
-303,238
| -2% | -$15.9M | 0.27% | 65 |
|
|
2023
Q3 | $986M | Sell |
16,996,263
-438,424
| -3% | -$26.9M | 0.34% | 45 |
|
|
2023
Q2 | $1.11B | Buy |
17,434,687
+856,985
| +5% | +$57.5M | 0.36% | 45 |
|
|
2023
Q1 | $1.15B | Buy |
16,577,702
+69,552
| +0.4% | +$4.91M | 0.41% | 39 |
|
|
2022
Q4 | $1.19B | Buy |
16,508,150
+6,578
| +0% | +$496K | 0.46% | 36 |
|
|
2022
Q3 | $1.17B | Sell |
16,501,572
-551,586
| -3% | -$40M | 0.46% | 32 |
|
|
2022
Q2 | $1.31B | Buy |
17,053,158
+674,921
| +4% | +$51.4M | 0.46% | 34 |
|
|
2022
Q1 | $1.2B | Buy |
16,378,237
+1,188,644
| +8% | +$79.8M | 0.36% | 48 |
|
|
2021
Q4 | $947M | Sell |
15,189,593
-632,124
| -4% | -$37.1M | 0.29% | 61 |
|
|
2021
Q3 | $936M | Buy |
15,821,717
+741,489
| +5% | +$48.8M | 0.3% | 58 |
|
|
2021
Q2 | $1.01B | Buy |
15,080,228
+697,349
| +5% | +$45.5M | 0.34% | 54 |
|
|
2021
Q1 | $908M | Sell |
14,382,879
-85,320
| -0.6% | -$5.31M | 0.34% | 55 |
|
|
2020
Q4 | $897M | Buy |
14,468,199
+155,917
| +1% | +$9.59M | 0.35% | 51 |
|
|
2020
Q3 | $863M | Sell |
14,312,282
-447,296
| -3% | -$26.9M | 0.39% | 50 |
|
|
2020
Q2 | $868M | Sell |
14,759,578
-689,293
| -4% | -$41.2M | 0.42% | 46 |
|
|
2020
Q1 | $862M | Buy |
15,448,871
+234,035
| +2% | +$14.3M | 0.5% | 35 |
|
|
2019
Q4 | $977M | Buy |
15,214,836
+4,558,218
| +43% | +$261M | 0.47% | 34 |
|
|
2019
Q3 | $540M | Buy |
10,656,618
+66,392
| +0.6% | +$3.12M | 0.28% | 69 |
|
|
2019
Q2 | $480M | Buy |
10,590,226
+415,853
| +4% | +$19.4M | 0.26% | 78 |
|
|
2019
Q1 | $485M | Buy |
10,174,373
+1,605,928
| +19% | +$80M | 0.28% | 72 |
|
|
2018
Q4 | $445M | Buy |
8,568,445
+474,820
| +6% | +$25.5M | 0.35% | 57 |
|
|
2018
Q3 | $502M | Buy |
8,093,625
+121,647
| +2% | +$7.22M | 0.36% | 52 |
|
|
2018
Q2 | $441M | Sell |
7,971,978
-66,471
| -0.8% | -$3.59M | 0.34% | 55 |
|
|
2018
Q1 | $508M | Sell |
8,038,449
-445,262
| -5% | -$28.6M | 0.39% | 48 |
|
|
2017
Q4 | $520M | Sell |
8,483,711
-138,941
| -2% | -$8.69M | 0.38% | 49 |
|
|
2017
Q3 | $550M | Buy |
8,622,652
+191,304
| +2% | +$11.2M | 0.41% | 46 |
|
|
2017
Q2 | $470M | Buy |
8,431,348
+217,920
| +3% | +$11.9M | 0.38% | 46 |
|
|
2017
Q1 | $447M | Buy |
8,213,428
+335,795
| +4% | +$18.4M | 0.38% | 45 |
|
|
2016
Q4 | $460M | Sell |
7,877,633
-33,535
| -0.4% | -$1.83M | 0.43% | 42 |
|
|
2016
Q3 | $427M | Sell |
7,911,168
-20,912
| -0.3% | -$1.34M | 0.43% | 45 |
|
|
2016
Q2 | $583M | Buy |
7,932,080
+347,094
| +5% | +$24.5M | 0.61% | 35 |
|
|
2016
Q1 | $485M | Buy |
7,584,986
+100,013
| +1% | +$6.31M | 0.54% | 39 |
|
|
2015
Q4 | $515M | Buy |
7,484,973
+74,490
| +1% | +$4.92M | 0.58% | 36 |
|
|
2015
Q3 | $439M | Buy |
7,410,483
+294,001
| +4% | +$18.7M | 0.53% | 37 |
|
|
2015
Q2 | $473M | Sell |
7,116,482
-173,987
| -2% | -$11.5M | 0.56% | 36 |
|
|
2015
Q1 | $470M | Buy |
7,290,469
+66,023
| +0.9% | +$4.13M | 0.56% | 36 |
|
|
2014
Q4 | $427M | Sell |
7,224,446
-175,520
| -2% | -$9.9M | 0.5% | 40 |
|
|
2014
Q3 | $379M | Sell |
7,399,966
-290,152
| -4% | -$14.5M | 0.45% | 47 |
|
|
2014
Q2 | $373M | Buy |
7,690,118
+318,205
| +4% | +$15.7M | 0.43% | 47 |
|
|
2014
Q1 | $383M | Sell |
7,371,913
-143,351
| -2% | -$7.63M | 0.47% | 44 |
|
|
2013
Q4 | $399M | Sell |
7,515,264
-48
| -0% | -$2.44K | 0.48% | 42 |
|
|
2013
Q3 | $348M | Buy |
7,515,312
+16,727
| +0.2% | +$734K | 0.46% | 45 |
|
|
2013
Q2 | $335M | Buy |
+7,498,585
| New | +$326M | 0.46% | 42 |
|
Other funds holding BMY
VCM
VPM
Legal & General Group's BMY Position: Q1 2026 in Review
Legal & General Group reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, selling an estimated $28.5M and leaving 16,877,626 shares worth $1.02B. The position accounts for 0.24% of the portfolio, ranked #76.
Legal & General Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.31B in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Legal & General Group held 16,877,626 shares of Bristol-Myers Squibb worth $1.02B as of Q1 2026.
- Legal & General Group sold 488,406 Bristol-Myers Squibb shares in Q1 2026, an estimated $28.5M.
- Bristol-Myers Squibb made up 0.24% of Legal & General Group's portfolio in Q1 2026, its #76 holding.
- Legal & General Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's Bristol-Myers Squibb position peaked at $1.31B in Q2 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.